Liver transplantation (1).

PubWeight™: 4.53‹?› | Rank: Top 1%

🔗 View Article (PMC 3091023)

Published in N Engl J Med on October 12, 1989


T E Starzl1, A J Demetris, D Van Thiel

Author Affiliations

1: Department of Surgery, University of Pittsburgh, PA.

Articles citing this

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg (1994) 4.24

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31

The hepatotropic influence of cyclosporine. Surgery (1990) 2.27

Jaundice at 14 days of age: exclude biliary atresia. Arch Dis Child (1991) 1.61

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J Exp Med (1995) 1.42

Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. Arch Dis Child (1993) 1.36

Transplantation in HIV+ patients. Transplantation (1990) 1.29

Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology (1992) 1.24

Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation (1994) 1.21

Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B. Proc Natl Acad Sci U S A (1990) 1.15

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis (1992) 1.12

FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology (1991) 1.05

Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg (1996) 0.96

The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991. J Surg Oncol Suppl (1993) 0.95

The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology (2006) 0.93

History of clinical transplantation. World J Surg (2000) 0.91

Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg (2004) 0.90

Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr (1993) 0.89

Hamster coagulation and serum proteins in rat recipients of hamster xenografts. Transplantation (1993) 0.88

Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut (1992) 0.87

Liver disease in infancy: a 20 year perspective. Gut (1991) 0.86

Liver transplantation in patients with previous portasystemic shunt. Am J Surg (1990) 0.86

Liver transplantation. Experience with 100 cases. West J Med (1991) 0.86

Liver disease in a district hospital remote from a transplant centre: a study of admissions and deaths. Gut (1992) 0.85

Heme oxygenase-1 overexpression increases liver injury after bile duct ligation in rats. World J Gastroenterol (2007) 0.85

Metabolic effects of liver transplantation in cirrhotic patients. J Clin Invest (1997) 0.85

Renal dysfunction associated with liver transplantation. Postgrad Med J (1995) 0.83

The relationship of systemic hemodynamics and oxygen consumption to early allograft failure after liver transplantation. Transpl Int (1993) 0.83

Dietary glycine blunts liver injury after bile duct ligation in rats. World J Gastroenterol (2008) 0.82

Contrast-enhanced ultrasound with SonoVue in the evaluation of postoperative complications in pediatric liver transplant recipients. J Ultrasound (2007) 0.81

Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis. PLoS One (2014) 0.81

Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc (2001) 0.81

Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc (1995) 0.80

The Future of Xenotransplantation. Ann Surg (1992) 0.80

Orthotopic liver transplantation in liver-based metabolic disorders. Eur J Pediatr (1992) 0.80

Requirements for transfusion and postoperative outcomes in orthotopic liver transplantation: a meta-analysis on aprotinin. World J Gastroenterol (2008) 0.79

Pre- and post-transplant assessment of liver function in paediatric liver transplantation. Eur J Pediatr (1992) 0.79

Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc (1997) 0.79

The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp (1995) 0.79

Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation. Gastroenterol Hepatol (N Y) (2014) 0.79

Interventional treatment for portal venous occlusion after liver transplantation: long-term follow-up results. Medicine (Baltimore) (2015) 0.79

Epigallocatechin 3-gallate ameliorates bile duct ligation induced liver injury in mice by modulation of mitochondrial oxidative stress and inflammation. PLoS One (2015) 0.78

Intraoperative blood loss in orthotopic liver transplantation: The predictive factors. World J Gastrointest Surg (2015) 0.78

A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award. J Clin Invest (2012) 0.76

Hyaluronate levels in donor organ washout effluents: a simple and predictive parameter of graft viability. Liver (1996) 0.75

Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75

Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives. World J Gastroenterol (2016) 0.75

Aspects of liver transplant pathology with emphasis on rejection and its mechanisms. J Clin Pathol (1994) 0.75

Is liver transplantation using organs donated after cardiac death cost-effective or does it decrease waitlist death by increasing recipient death? HPB (Oxford) (2012) 0.75

Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc (1991) 0.75

Anthony Cerami Award in Translational Medicine: A Journey in Science: The Birth of Organ Transplantation with Particular Reference to Alloengraftment Mechanisms. Mol Med (2015) 0.75

Cu isotopic signature in blood serum of liver transplant patients: a follow-up study. Sci Rep (2016) 0.75

Orthotopic liver transplantation for hemochromatosis. Transplant Proc (1991) 0.75

Protective Effects of Guava Pulp on Cholestatic Liver Injury. ISRN Hepatol (2013) 0.75

Does the presence of a measurable blood alcohol level in a potential organ donor affect the outcome of liver transplantation? Alcohol Clin Exp Res (1991) 0.75

The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75

Orthotopic liver transplantation for hepatitis C infection: the best Christmas present? Ulster Med J (1998) 0.75

Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers. Xenotransplantation (1997) 0.75

Baicalin Ameliorates Experimental Liver Cholestasis in Mice by Modulation of Oxidative Stress, Inflammation, and NRF2 Transcription Factor. Oxid Med Cell Longev (2017) 0.75

[Liver transplantation and pregnancy: 1994 perspectives]. Arch Gynecol Obstet (1994) 0.75

Articles cited by this

(truncated to the top 100)

Evolution of liver transplantation. Hepatology (1982) 19.54


Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

Prognosis in primary biliary cirrhosis: model for decision making. Hepatology (1989) 3.83

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Extended preservation of the liver for clinical transplantation. Lancet (1988) 2.89

Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87

A new technique for biliary drainage in orthotopic liver transplantation utilizing the gall bladder as a pedicle graft conduit between the donor and recipient common bile ducts. Ann Surg (1976) 2.86

Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85

Reduced-sized orthotopic liver graft in hepatic transplantation in children. Surgery (1984) 2.63

Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet (1985) 2.59

Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58

National Institutes of Health Consensus Development Conference Statement: liver transplantation--June 20-23, 1983. Hepatology (1984) 2.50

Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med (1984) 2.44

Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis (1986) 2.39

Liver transplantation across ABO blood groups. Surgery (1986) 2.39

The antibody crossmatch in liver transplantation. Surgery (1986) 2.33

Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis (1985) 2.16

Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg (1987) 2.11

Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics (1986) 2.04

Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med (1980) 2.00

Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94

Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc (1987) 1.90

The first 100 liver transplants at UCLA. Ann Surg (1987) 1.84

Biliary Tract Complications in Liver Transplantation Under Cyclosporin-Steroid Therapy. Transplant Proc (1983) 1.82

Sinusoidal lining cell damage: the critical injury in cold preservation of liver allografts in the rat. Transplantation (1988) 1.78

Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74

Hepatic artery in liver transplantation. Transplant Proc (1987) 1.73

Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc (1973) 1.73

Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol (1986) 1.73

Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? Transplantation (1989) 1.67

The application of bone marrow transplantation to the treatment of genetic diseases. Science (1986) 1.62

Cyclosporin-induced endothelial cell injury. Lab Invest (1986) 1.60

Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation (1989) 1.58

Liver transplantation for fulminant hepatic failure. Semin Liver Dis (1985) 1.56

Emergency liver transplantation for fulminant hepatitis. Ann Intern Med (1987) 1.56

Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet (1977) 1.51

The effect of liver transplantation in a 13-year-old boy with erythropoietic protoporphyria. Transplantation (1988) 1.51

Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Med (1989) 1.50

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45

Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg (1988) 1.44

Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation (1988) 1.39

Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transplant Proc (1988) 1.38

Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology (1988) 1.32

Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr (1985) 1.32

Liver transplantation in a hemophiliac. N Engl J Med (1985) 1.32

Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection. Transplantation (1987) 1.31

Signs of hyperacute rejection of liver grafts in rhesus monkeys after donor-specific presensitization. Transplant Proc (1987) 1.30

Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med (1988) 1.24

Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol (1987) 1.24

Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation (1986) 1.24

Liver transplantation. Transplant Proc (1987) 1.23

Comparison of UW with other solutions for liver preservation in dogs. Clin Transplant (1989) 1.20

Liver transplantation in older patients. N Engl J Med (1987) 1.20

Liver transplantation for type I glycogen storage disease. Lancet (1983) 1.20

A new technique of hepatic vein reconstruction in partial liver transplantation. Transpl Int (1988) 1.19

Liver transplantation in cystic fibrosis. Lancet (1989) 1.15

The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13

Liver transplantation in the treatment of bleeding esophageal varices. Surgery (1988) 1.11

Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet (1987) 1.10

Liver transplantation for malignant tumors. Gastroenterol Clin North Am (1988) 1.09

Hyperacute rejection in liver transplantation: a case report. Transplant Proc (1989) 1.07

Liver transplantation without venous bypass. Transplantation (1987) 1.04

Metabolism during hepatic transplantation: indicators of allograft function. Surgery (1984) 1.02

Infection with human immunodeficiency virus in the Pittsburgh transplant population. A study of 583 donors and 1043 recipients, 1981-1986. Transplantation (1989) 1.02

Doppler ultrasound as a screen for hepatic artery thrombosis after liver transplantation. Transplantation (1986) 1.00

Approach to management of the heartbeating 'brain dead' organ donor. JAMA (1989) 1.00

Analysis of biliary complications following orthotopic liver transplantation. Transplant Proc (1989) 0.99

Orthotopic liver transplantation totally corrects factor IX deficiency in hemophilia B. Surgery (1988) 0.99

Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation (1989) 0.97

The acquired immunodeficiency syndrome and transplantation. Transplantation (1987) 0.95

Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet (1988) 0.95

Protein C deficiency and portal thrombosis in liver transplantation in children. Lancet (1988) 0.95

Liver transplantation in the Cambridge/King's College Hospital series--the first 400 patients. Transplant Proc (1989) 0.95

Raised hematocrit--a contributing factor to hepatic artery thrombosis following liver transplantation. Transplantation (1988) 0.94

Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin overproduction. Gastroenterology (1988) 0.93

Portal and arterial thrombosis in liver transplantation: a frequent event in severe rejection. Transplant Proc (1989) 0.92

Liver grafting for malignant liver tumors. Transplant Proc (1989) 0.92

Donor data in liver grafts with primary non-function--a preliminary analysis by the European Liver Registry. Transplant Proc (1989) 0.92

The successful management of portal vein thrombosis after hepatic transplantation with a splenorenal shunt. Surg Gynecol Obstet (1988) 0.88

Hepatic artery thrombosis after orthotopic liver transplantation--a fatal complication or an asymptomatic event. Transplant Proc (1989) 0.86

Survival from hepatic transplantation. Relationship of protein synthesis to histological abnormalities in patient selection and postoperative management. Ann Surg (1986) 0.86

Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol (1984) 0.85

Liver transplantation in Crigler-Najjar syndrome. A case report. Transplantation (1986) 0.85

Late complications with gallbladder conduit biliary reconstruction after liver transplantation. Transplantation (1989) 0.84

Transfer of congenital factor XI deficiency from a donor to a recipient by liver transplantation. N Engl J Med (1987) 0.84

Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg (1988) 0.83

Distal splenorenal shunt for portal vein thrombosis after liver transplantation. Am J Gastroenterol (1989) 0.82

Orthotopic liver transplantation for massive hepatic lymphangiomatosis. Surgery (1988) 0.81

Articles by these authors

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet (1994) 5.54

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Baboon-to-human liver transplantation. Lancet (1993) 4.01

Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. Transplant Proc (1987) 3.55

Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation (1993) 3.13

Orthotopic liver transplantation in dogs receiving FK-506. Transplant Proc (1987) 3.11

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Liver transplantation (2). N Engl J Med (1989) 2.93

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91

Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg (2000) 2.91

The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81

A review of adult and pediatric post-transplant liver pathology. Pathol Annu (1987) 2.62

FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50

Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med (1994) 2.48

Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38

FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29

Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc (1991) 2.28

Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28

Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg (1995) 2.25

Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation (1992) 2.20

Transplantation milestones. Viewed with one- and two-way paradigms of tolerance. JAMA (1995) 2.20

Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation (1993) 2.17

Left hepatic trisegmentectomy. Surg Gynecol Obstet (1982) 2.16

Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation (1993) 2.14

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09

Pathology of human intestinal transplantation. Gastroenterology (1996) 1.98

Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation (1997) 1.98

Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation (1991) 1.95

Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation (1993) 1.94

Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93

Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells (1995) 1.83

The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83

Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation (1985) 1.75

Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74

Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. Transplant Proc (1993) 1.72

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg (2005) 1.70

Transplantation tolerance, microchimerism, and the two-way paradigm. Theor Med Bioeth (1998) 1.67

Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation (1996) 1.65

Cyclosporine A augments the regenerative response after partial hepatectomy in the rat. Transplant Proc (1988) 1.64

Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology (1999) 1.64

Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol (1986) 1.63

Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61

Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet (1992) 1.61

Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant (2009) 1.59

Weaning of immunosuppression in long-term liver transplant recipients. Transplantation (1995) 1.59

Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation (1989) 1.58

Weaning of immunosuppression in liver transplant recipients. Transplantation (1997) 1.57

The biological basis of and strategies for clinical xenotransplantation. Immunol Rev (1994) 1.56

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation (2000) 1.53

Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52

Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathological analysis, and pathogenetic hypothesis. Hepatology (1997) 1.52

Drug development and testing in relation to cell migration and chimerism. Transplant Proc (1993) 1.52

"Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant (2013) 1.52

The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A (1985) 1.51

Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50

Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology (1994) 1.49

FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery (1991) 1.49

Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. Transplantation (1995) 1.45

Orthotopic liver transplantation for alcoholic cirrhosis. JAMA (1988) 1.45

Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer (1992) 1.45

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Recurrent hepatic allograft injury in erythropoietic protoporphyria. Transplantation (1996) 1.41

Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology (1998) 1.41

Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology (1990) 1.38

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet (1992) 1.32

The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32

Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol (1990) 1.31

The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol (2000) 1.31

A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology (1989) 1.30

Canine total orthotopic small bowel transplantation under FK 506. Transplant Proc (1991) 1.29